Minyue Zhang

792 total citations
25 papers, 526 citations indexed

About

Minyue Zhang is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Minyue Zhang has authored 25 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Minyue Zhang's work include Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Minyue Zhang is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Minyue Zhang collaborates with scholars based in China, Hong Kong and United States. Minyue Zhang's co-authors include Ruifeng Luo, Fei Gao, Yichen Hu, Jinming Zhang, Haiting Xu, Fangyuan Chen, Hongling Du, Honghui Huang, Lingling Dong and Qiyan Chen and has published in prestigious journals such as Blood, Cancer and Cancer Research.

In The Last Decade

Minyue Zhang

25 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minyue Zhang China 10 190 93 73 72 72 25 526
Kwan Man Hong Kong 9 204 1.1× 149 1.6× 65 0.9× 51 0.7× 72 1.0× 14 435
Kan Chen China 18 226 1.2× 96 1.0× 148 2.0× 89 1.2× 166 2.3× 36 912
Wenjiao Zeng China 13 228 1.2× 106 1.1× 106 1.5× 17 0.2× 83 1.2× 26 606
Ruichuang Yang China 13 275 1.4× 66 0.7× 101 1.4× 20 0.3× 76 1.1× 21 586
Wenxia Yao China 14 246 1.3× 82 0.9× 38 0.5× 19 0.3× 68 0.9× 27 496
Federico Moriconi Germany 16 182 1.0× 146 1.6× 112 1.5× 52 0.7× 129 1.8× 34 712
Qian Qiao China 12 239 1.3× 74 0.8× 66 0.9× 15 0.2× 41 0.6× 25 439
Jinwei Chen China 13 163 0.9× 104 1.1× 49 0.7× 40 0.6× 44 0.6× 40 627

Countries citing papers authored by Minyue Zhang

Since Specialization
Citations

This map shows the geographic impact of Minyue Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minyue Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minyue Zhang more than expected).

Fields of papers citing papers by Minyue Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minyue Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minyue Zhang. The network helps show where Minyue Zhang may publish in the future.

Co-authorship network of co-authors of Minyue Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Minyue Zhang. A scholar is included among the top collaborators of Minyue Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minyue Zhang. Minyue Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Junying, Mengping Chen, Xin Li, et al.. (2025). Targeting deubiquitinase USP7-mediated stabilization of XPO1 contributes to the anti-myeloma effects of selinexor. Journal of Translational Medicine. 23(1). 62–62. 2 indexed citations
2.
Liu, Jia, Yaoxin Zhang, Changming Shih, et al.. (2025). Enhancer Extrachromosomal Circular DNA ANKRD28 Elicits Drug Resistance via POU2F2‐Mediated Transcriptional Network in Multiple Myeloma. Advanced Science. 12(21). e2415695–e2415695. 3 indexed citations
3.
Yao, Yang, Minyue Zhang, Di Liu, et al.. (2024). Changes in systemic immune-inflammation index (SII) predict the prognosis of patients with hepatitis B-related hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors. Clinical & Translational Oncology. 27(3). 1155–1165. 2 indexed citations
4.
Li, Zihua, Minyue Zhang, Massimo Federico, et al.. (2024). Early histological transformation of follicular lymphoma to diffuse large B‐cell lymphoma indicating adverse survival: A population‐based analysis and validation. Cancer. 130(19). 3321–3332. 2 indexed citations
5.
Zhang, Minyue, Fei Xiao, Meisi Lin, et al.. (2022). The epidemiology and prognosis of patients with primary gastric T‐cell lymphoma in the SEER program. Cancer Medicine. 12(1). 84–98. 2 indexed citations
6.
Lin, Meisi, Rita Yim, Qiyan Chen, et al.. (2022). Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia. BMC Cancer. 22(1). 1068–1068. 9 indexed citations
7.
Xu, Haiting, Wenbiao Nie, Ruifeng Luo, et al.. (2022). Recent advances in natural polysaccharides-based controlled release nanosystems for anti-cancer phototherapy. Carbohydrate Polymers. 301(Pt A). 120311–120311. 39 indexed citations
8.
Dong, Lingling, Hongling Du, Minyue Zhang, et al.. (2022). Anti‐inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K/Akt/mTOR signaling pathway and regulating gut microbiota. Phytotherapy Research. 36(5). 2081–2094. 132 indexed citations
9.
Zhang, Minyue, Fei Gao, Ling Peng, et al.. (2021). Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin’s lymphoma: a systematic review and meta-analysis. Cancer Cell International. 21(1). 524–524. 9 indexed citations
11.
Luo, Ruifeng, Meisi Lin, Chen Zhang, et al.. (2020). Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis. Food Chemistry. 330. 127241–127241. 85 indexed citations
13.
Zhang, Minyue, Gui‐Qi Zhu, Ji-Na Zheng, et al.. (2017). Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis. Expert Review of Anti-infective Therapy. 15(5). 503–513. 15 indexed citations
14.
Wang, Qingyuan, et al.. (2016). A preliminary study on epigenetic regulation of Acanthopanax senticosus in leukemia cell lines. Experimental Hematology. 44(6). 466–473. 10 indexed citations
15.
Huang, Honghui, Fei Xiao, Hua Zhong, et al.. (2016). Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma. Nuclear Medicine Communications. 37(7). 689–698. 14 indexed citations
16.
Zhang, Minyue, Fangyuan Chen, & Hua Zhong. (2011). Meta-analysis of human leukocyte antigen genetic polymorphisms and susceptibility to chronic myelogenous leukemia in Chinese population. Leukemia Research. 35(12). 1564–1570. 8 indexed citations
17.
Zhang, Minyue, et al.. (2010). Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to Alzheimer's disease. Neuroscience Research. 68(2). 142–150. 41 indexed citations
18.
Chua, Daniel T. T., Jonathan S. T. Sham, Minyue Zhang, et al.. (2009). Increased expression of annexin I is associated with drug‐resistance in nasopharyngeal carcinoma and other solid tumors. PROTEOMICS - CLINICAL APPLICATIONS. 3(6). 654–662. 16 indexed citations
19.
Chua, Daniel, Mandy Ng, Li Fu, et al.. (2006). High-throughput Loss-of-Heterozygosity Study of Chromosome 3p in Lung Cancer Using Single-Nucleotide Polymorphism Markers. Cancer Research. 66(8). 4133–4138. 47 indexed citations
20.
Ni, Cheng, et al.. (2003). A specific anti-Helicobacter pylori agent NE2001: synthesis and its effect on the growth of H. pylori. Bioorganic & Medicinal Chemistry Letters. 13(16). 2703–2707. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026